Hospital Universitario De Jaen

At Hospital Universitario De Jaen, a major share of the clinical trial portfolio focuses on neoplasms, especially breast cancer. Research includes early-stage, locally advanced, metastatic, and high-risk disease, with studies designed to improve treatment effectiveness, reduce recurrence, and refine care after surgery or neoadjuvant therapy.

• Hormone receptor-positive and HER2-negative breast cancer
• HER2-positive and triple-negative breast cancer
• Metastatic and high-risk early breast cancer
• Testing new combinations and supportive strategies to improve outcomes

This work reflects a strong focus on modern oncology care, with trials aimed at better disease control and more personalized treatment choices.

Another prominent area is respiratory tract disease research, particularly non-small cell lung cancer and small cell lung cancer. The trials explore treatment options for advanced, metastatic, and resectable disease, including studies that assess whether newer therapies can improve survival, delay progression, or support care after surgery.

• Advanced and metastatic non-small cell lung cancer
• Small cell lung cancer and limited-stage disease
• EGFR-, RET-, KRAS-, and PD-L1-related lung cancer research
• Evaluating new targeted and immunotherapy-based approaches

This area shows active investigation into more precise and effective treatment strategies for complex lung cancer cases.

The site also studies a broad range of other solid tumors, including ovarian cancer, endometrial cancer, head and neck squamous cell carcinoma, hepatocellular carcinoma, and prostate cancer. These trials often aim to improve disease control in advanced or recurrent settings and to test whether new regimens can offer better outcomes for patients with limited options.

• Ovarian, endometrial, and fallopian tube cancers
• Head and neck cancer and hepatocellular carcinoma
• Metastatic and unresectable solid tumors
• Assessing new therapies for harder-to-treat cancers

The research portfolio highlights a broad oncology focus beyond breast and lung cancer, with attention to both tumor control and long-term benefit.

Clinical trials at the site also address cardiovascular diseases and nutritional and metabolic diseases. Research includes conditions such as atherosclerotic cardiovascular disease, hypertension, spontaneous coronary artery dissection, transthyretin amyloid cardiomyopathy, and type 2 diabetes, with studies focused on improving prevention and treatment.

• Atherosclerotic cardiovascular disease and elevated lipoprotein(a)
• Hypertension, heart failure, and coronary disorders
• Type 2 diabetes and severe hypertriglyceridemia
• Testing therapies that may reduce events and improve long-term health

This research supports better management of chronic cardiometabolic conditions that affect many adults.

The trial landscape at Hospital Universitario De Jaen includes studies in bacterial infections and mycoses, immune system diseases, and skin and connective tissue diseases. Examples include bacteremia, septic shock, allergic rhinitis with asthma, and atopic dermatitis, with research aimed at improving treatment effectiveness, safety, and symptom control.

• Bloodstream infections and septic shock
• Allergic and immune-mediated conditions
• Atopic dermatitis and related skin disease
• Comparing treatments to improve outcomes and reduce side effects

These studies show a balanced interest in both acute infectious disease care and longer-term immune-mediated conditions.